IBDEI05V ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7585,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,7585,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,7585,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,7586,0)
 ;;=054.40^^53^467^42
 ;;^UTILITY(U,$J,358.3,7586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7586,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,7586,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,7586,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,7587,0)
 ;;=190.1^^53^467^82
 ;;^UTILITY(U,$J,358.3,7587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7587,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,7587,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,7587,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,7588,0)
 ;;=190.2^^53^467^50
 ;;^UTILITY(U,$J,358.3,7588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7588,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,7588,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,7588,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,7589,0)
 ;;=190.7^^53^467^52
 ;;^UTILITY(U,$J,358.3,7589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7589,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,7589,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,7589,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,7590,0)
 ;;=202.81^^53^467^61
 ;;^UTILITY(U,$J,358.3,7590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7590,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,7590,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,7590,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,7591,0)
 ;;=215.9^^53^467^84
 ;;^UTILITY(U,$J,358.3,7591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7591,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,7591,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,7591,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,7592,0)
 ;;=224.2^^53^467^51
 ;;^UTILITY(U,$J,358.3,7592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7592,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,7592,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,7592,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,7593,0)
 ;;=224.5^^53^467^95
 ;;^UTILITY(U,$J,358.3,7593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7593,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,7593,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,7593,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,7594,0)
 ;;=224.7^^53^467^28
 ;;^UTILITY(U,$J,358.3,7594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7594,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,7594,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,7594,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,7595,0)
 ;;=237.70^^53^467^66
 ;;^UTILITY(U,$J,358.3,7595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7595,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,7595,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,7595,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,7596,0)
 ;;=239.6^^53^467^65
 ;;^UTILITY(U,$J,358.3,7596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7596,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,7596,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,7596,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,7597,0)
 ;;=239.81^^53^467^96
 ;;^UTILITY(U,$J,358.3,7597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7597,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,7597,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,7597,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,7598,0)
 ;;=272.0^^53^467^48
 ;;^UTILITY(U,$J,358.3,7598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7598,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,7598,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,7598,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,7599,0)
 ;;=340.^^53^467^63
 ;;^UTILITY(U,$J,358.3,7599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7599,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,7599,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,7599,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,7600,0)
 ;;=345.90^^53^467^29
 ;;^UTILITY(U,$J,358.3,7600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7600,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,7600,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,7600,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,7601,0)
 ;;=368.02^^53^467^23
 ;;^UTILITY(U,$J,358.3,7601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7601,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,7601,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,7601,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,7602,0)
 ;;=368.11^^53^467^102
 ;;^UTILITY(U,$J,358.3,7602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7602,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,7602,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,7602,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,7603,0)
 ;;=368.59^^53^467^11
 ;;^UTILITY(U,$J,358.3,7603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7603,1,3,0)
 ;;=3^Color Blindness
 ;;^UTILITY(U,$J,358.3,7603,1,4,0)
 ;;=4^368.59
 ;;^UTILITY(U,$J,358.3,7603,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,7604,0)
 ;;=368.60^^53^467^67
 ;;^UTILITY(U,$J,358.3,7604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7604,1,3,0)
 ;;=3^Night Blindness
 ;;^UTILITY(U,$J,358.3,7604,1,4,0)
 ;;=4^368.60
 ;;^UTILITY(U,$J,358.3,7604,2)
 ;;=^83350
 ;;^UTILITY(U,$J,358.3,7605,0)
 ;;=368.9^^53^467^113
 ;;^UTILITY(U,$J,358.3,7605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7605,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,7605,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,7605,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,7606,0)
 ;;=369.00^^53^467^108
 ;;^UTILITY(U,$J,358.3,7606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7606,1,3,0)
 ;;=3^Total Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,7606,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,7606,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,7607,0)
 ;;=369.01^^53^467^109
 ;;^UTILITY(U,$J,358.3,7607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7607,1,3,0)
 ;;=3^Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,7607,1,4,0)
 ;;=4^369.01
 ;;^UTILITY(U,$J,358.3,7607,2)
 ;;=^268861
 ;;^UTILITY(U,$J,358.3,7608,0)
 ;;=369.02^^53^467^75
 ;;^UTILITY(U,$J,358.3,7608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7608,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye-NOS
 ;;^UTILITY(U,$J,358.3,7608,1,4,0)
 ;;=4^369.02
 ;;^UTILITY(U,$J,358.3,7608,2)
 ;;=^268862
 ;;^UTILITY(U,$J,358.3,7609,0)
 ;;=369.03^^53^467^74
 ;;^UTILITY(U,$J,358.3,7609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7609,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye Total
 ;;^UTILITY(U,$J,358.3,7609,1,4,0)
 ;;=4^369.03
 ;;^UTILITY(U,$J,358.3,7609,2)
 ;;=^268863
 ;;^UTILITY(U,$J,358.3,7610,0)
 ;;=369.04^^53^467^64
 ;;^UTILITY(U,$J,358.3,7610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7610,1,3,0)
 ;;=3^Near Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,7610,1,4,0)
 ;;=4^369.04
 ;;^UTILITY(U,$J,358.3,7610,2)
 ;;=^268864
 ;;^UTILITY(U,$J,358.3,7611,0)
 ;;=369.06^^53^467^77
 ;;^UTILITY(U,$J,358.3,7611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7611,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,7611,1,4,0)
 ;;=4^369.06
 ;;^UTILITY(U,$J,358.3,7611,2)
 ;;=^268866
 ;;^UTILITY(U,$J,358.3,7612,0)
 ;;=369.07^^53^467^76
 ;;^UTILITY(U,$J,358.3,7612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7612,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Near
 ;;^UTILITY(U,$J,358.3,7612,1,4,0)
 ;;=4^369.07
 ;;^UTILITY(U,$J,358.3,7612,2)
 ;;=^268867
 ;;^UTILITY(U,$J,358.3,7613,0)
 ;;=369.08^^53^467^91
 ;;^UTILITY(U,$J,358.3,7613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7613,1,3,0)
 ;;=3^Profound Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,7613,1,4,0)
 ;;=4^369.08
 ;;^UTILITY(U,$J,358.3,7613,2)
 ;;=^268868
 ;;^UTILITY(U,$J,358.3,7614,0)
 ;;=369.10^^53^467^73
 ;;^UTILITY(U,$J,358.3,7614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7614,1,3,0)
 ;;=3^One Eye-Blind,Oth-Low Vision
 ;;^UTILITY(U,$J,358.3,7614,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,7614,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,7615,0)
 ;;=369.11^^53^467^78
 ;;^UTILITY(U,$J,358.3,7615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7615,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Blind
 ;;^UTILITY(U,$J,358.3,7615,1,4,0)
 ;;=4^369.11
 ;;^UTILITY(U,$J,358.3,7615,2)
 ;;=^268871
 ;;^UTILITY(U,$J,358.3,7616,0)
 ;;=369.12^^53^467^81
 ;;^UTILITY(U,$J,358.3,7616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7616,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,7616,1,4,0)
 ;;=4^369.12
 ;;^UTILITY(U,$J,358.3,7616,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,7617,0)
 ;;=369.13^^53^467^79
 ;;^UTILITY(U,$J,358.3,7617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7617,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Near Total
 ;;^UTILITY(U,$J,358.3,7617,1,4,0)
 ;;=4^369.13
 ;;^UTILITY(U,$J,358.3,7617,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,7618,0)
 ;;=369.14^^53^467^80
 ;;^UTILITY(U,$J,358.3,7618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7618,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Profound
 ;;^UTILITY(U,$J,358.3,7618,1,4,0)
 ;;=4^369.14
 ;;^UTILITY(U,$J,358.3,7618,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,7619,0)
 ;;=369.22^^53^467^101
 ;;^UTILITY(U,$J,358.3,7619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7619,1,3,0)
 ;;=3^Severe Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,7619,1,4,0)
 ;;=4^369.22
 ;;^UTILITY(U,$J,358.3,7619,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,7620,0)
 ;;=369.60^^53^467^6
 ;;^UTILITY(U,$J,358.3,7620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7620,1,3,0)
 ;;=3^Blindness,One Eye Only
 ;;^UTILITY(U,$J,358.3,7620,1,4,0)
 ;;=4^369.60
 ;;^UTILITY(U,$J,358.3,7620,2)
 ;;=^268880
 ;;^UTILITY(U,$J,358.3,7621,0)
 ;;=369.9^^53^467^114
 ;;^UTILITY(U,$J,358.3,7621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7621,1,3,0)
 ;;=3^Visual Loss NOS
 ;;^UTILITY(U,$J,358.3,7621,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,7621,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,7622,0)
 ;;=377.61^^53^467^20
 ;;^UTILITY(U,$J,358.3,7622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7622,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,7622,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,7622,2)
 ;;=^269241
